{"id":"NCT00401973","sponsor":"Eli Lilly and Company","briefTitle":"Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine","officialTitle":"The Assessment of the Safety, Efficacy, and Practicality of an Algorithm Including Amantadine, Metformin and Zonisamide for the Prevention of Olanzapine-Associated Weight Gain in Outpatients With Schizophrenia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-11","primaryCompletion":"2008-09","completion":"2008-09","firstPosted":"2006-11-22","resultsPosted":"2009-09-30","lastUpdate":"2009-10-06"},"enrollment":199,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Schizophrenia","Schizoaffective Disorders"],"interventions":[{"type":"DRUG","name":"olanzapine","otherNames":["LY170053","Zyprexa"]},{"type":"DRUG","name":"amantadine","otherNames":[]},{"type":"DRUG","name":"metformin","otherNames":[]},{"type":"DRUG","name":"zonisamide","otherNames":[]},{"type":"BEHAVIORAL","name":"Wellness education","otherNames":[]}],"arms":[{"label":"Olanzapine","type":"EXPERIMENTAL"},{"label":"Olanzapine + Amantadine","type":"EXPERIMENTAL"},{"label":"Olanzapine + Metformin","type":"EXPERIMENTAL"}],"summary":"The goal of this study is to answer the following questions:\n\n* Whether treatment with amantadine, metformin or zonisamide can prevent or reverse the weight gain that is associated with olanzapine\n* Whether taking amantadine, metformin or zonisamide can help patients decrease or eliminate some of the changes in body that occur with weight gain\n* How weight gain associated with olanzapine can affect people\n* Whether treatment with amantadine, metformin or zonisamide can help eliminate weight gain associated with olanzapine and not interfere with the positive effects of olanzapine on functioning of people with schizophrenia and other diseases","primaryOutcome":{"measure":"Change From Baseline to Endpoint in Weight","timeFrame":"Baseline to endpoint (22 weeks)","effectByArm":[{"arm":"Olanzapine","deltaMin":2.76,"sd":0.75},{"arm":"Olanzapine + Amantadine","deltaMin":2.4,"sd":0.65},{"arm":"Olanzapine + Metformin","deltaMin":0.65,"sd":0.63}],"pValues":[{"comp":"OG000 vs OG001 vs OG002","p":"0.065"},{"comp":"OG000 vs OG001","p":"0.113"},{"comp":"OG000 vs OG002","p":"0.036"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":15,"countries":["United States","Brazil","Israel","Mexico","Puerto Rico","Russia","South Korea"]},"refs":{"pmids":["21672497","20840778"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5},"commonTop":["Somnolence","Diarrhoea","Nausea","Weight increased","Insomnia"]}}